Audit Report

Siegfried Pharma Chemikalien Minden GmbH JA – 822

Audit #: JA - 822 and JA - 766
Region: Germany
Material: API/Excipients
Company: Siegfried Pharma Chemikalien Minden GmbH and BASF Pharmachemikalien GmbH
Location: Karlstrasse 15 Minden 32423 Germany
Date: 29-30 August 2017

This Rx-360 Audit Report contains the following scope:

The scope of the audit included the production, testing, packaging, storage and distribution of
Caffeine US Anhydrous
Dopamine HCl USP
Ephedrine Sulfate USP
Oxemetazoline Hydrochloride EP/USP
The audit was based on Rx-360 Consortium guidelines for APIs and excipients and supply
chain security component based on the Rx-360 Consortium Supply Chain Security Checklist.